Sex and gender gap in medical research by napa medical research Sex and gender gaps in medical research refer to the historical and ongoing underrepresentation of women and other marginalized genders in medical studies, clinical trials, and other forms of biomedical research. This gap has resulted in significant health disparities, including misdiagnosis, inadequate treatment, and adverse reactions to drugs, among other issues. Historically, medical research has primarily focused on men, and women and other genders were excluded from studies due to the belief that their hormonal fluctuations would introduce variability that would compromise the validity of the research. As a result, many treatments and medications were developed and tested primarily on men, leading to serious health consequences for women and other marginalized genders. Today, although there have been some improvements, women and other genders remain underrepresented in medical research. For example, a two thousand eighteen study found that women accounted for only thirty nine percent of participants in cardiovascular clinical trials published between two thousand ten and two thousand seventeen. Moreover, transgender and nonbinary individuals are often not included in medical research studies at all, further exacerbating the knowledge gaps surrounding their health. Addressing the sex and gender gap in medical research requires a concerted effort from researchers, funders, and policymakers to ensure that studies include diverse participants and that data is disaggregated by sex and gender to identify differences in disease prevalence, symptom presentation, and treatment outcomes. This will not only improve health outcomes for women and other marginalized genders but will also lead to more accurate and effective medical treatments for everyone. For more details visit us - https://www.napamedicalresearch.org/